Jennifer K. (Kristie) Johnson, Ph.D., D(ABMM)

JKJohnson

Curriculum Vitae

Jennifer K. (Kristie) Johnson, Ph.D., D(ABMM)

Associate Professor, Department of Pathology

University of MarylandSchool of Medicine

DateOctober 7, 2016

Contact Information

Business Address: 22 South Greene Street, Room N2W50B

Baltimore, Maryland 21201

Office Phone Number:(410) 328-6698

Laboratory Phone Number:(410) 706-7062

Fax:(410) 706-8414

Beeper:(410) 382-2337 x3977

Email:

Education

1992-1996B.S. Degree in Biology, minor in Chemistry, Salisbury State University

Salisbury, Maryland

1996-2002Ph.D. in Microbiology and Immunology, University of Maryland, Baltimore

Thesis: Analysis of the Specificity and Genetics of Antibodies to Soman.

Mentor: David E. Lenz, Ph.D.

1998-2000Rapid Transition Training Program, Categorical in Microbiology University of Maryland School of Medicine

Department of Medical and Research Technology

Postgraduate Education and Training

2003-2006Postdoctoral Fellowship, Department of Pathology, University of Maryland School of Medicine

Mentor: Richard A. Venezia, Ph.D., D(ABMM)

Certifications

1998-PresentTechnologist in Microbiology, American Society of Clinical Pathology Board of Certification

2010-PresentDiplomate in Public Health and Medical Microbiology, The American Boardof Medical Microbiology of the American Academy of Microbiology

Employment History

Academic Appointments

2006-2012Assistant Professor, Department of Pathology, University of Maryland School of Medicine (Primary appointment)

2007-PresentVA Research Health Scientist (WOC),Baltimore Veterans Administration

2011-2012Assistant Professor,Department of Epidemiology and Public HealthUniversity of MarylandSchool of Medicine (Secondary appointment)

2012-PresentAssociate Professor, Department of Pathology, University of Maryland School of Medicine (Primary appointment)

2012-PresentAssociate Professor,Department of Epidemiology and Public HealthUniversity of MarylandSchool of Medicine (Secondary appointment)

2013-PresentAssociate Professor,Department of Microbiology and ImmunologyUniversity of MarylandSchool of Medicine (Secondary appointment)

Other Employment

1996-1997 ORISE Fellow, Toxicology Division, Toxicology Evaluation Branch

US Army Center for HealthPromotion and Preventive Medicine

Aberdeen Proving Ground-Edgewood Area, Maryland 21010

1998Graduate Research Assistant, Department of Oral and Craniofacial Sciences

School of Dentistry

University of Maryland, Baltimore

1998-2002ORISE Fellow, Pharmacology Division, Biochemical Pharmacology Branch

US Army Medical Research Institute of Chemical Defense

Aberdeen Proving Ground-Edgewood Area, Maryland 21010

2003Scientist - Section Head

Rapid Diagnostics: Bioterrorism Response Section

MarylandDepartment of Health and Mental Hygiene

Professional Society Memberships

1997-Present National and Maryland Branch of American Society of Microbiology

2006-Present Pan American Society of Clinical Virology

2008-Present Association of Molecular Pathology

2013-PresentSociety of Healthcare Epidemiology

Honors and Awards

1999Excellence in Microbiology Award, University of Maryland School of Medicine

Department of Medical and Research Technology

2000-2001 Merit Scholarship Award, University of Maryland Dental School

2000-2002 NIH National Research Service Award Training Program

2011Richard S. Schwalbe Award, American Society of Microbiology, Maryland Branch

Clinical Activities

2006-2014Associate Director of Clinical Microbiology and Virology Laboratories

Laboratories of Pathology, University of Maryland Medical Center

• Clinical Microbiology Seminar Series
• Pace Lectures for Laboratory Staff
• Physician Consults
• Patient Rounds
• Clinical Plate Rounds
• Member
• Pandemic Steering Committee
• Executive Infection Control Committee
• Antimicrobial Subcommittee
• Ebola Steering Committee
• Moved all protocols to electronic and placed on share drive for all employees to view while working at the bench.
• Molecular Detection
• MRSA
• Influenza and RSV
• Respiratory viruses (10)
• Enterovirus
• Clostridium difficile
• PNA-FISH from positive blood cultures
• Surveillance
• MRSA
• Acinetobacter baumannii
• Carbapenem-Resistant Enterobacteriaceae
• Rapid Detection from Blood Cultures
• Antibiotic Resistance
• Fluconazole susceptibility in Candida species
• Carbapenemase detection in Enterobacteriaceae

2014-2015Interim Director of Clinical Microbiology and Virology Laboratories. Laboratories of Pathology, University of Maryland Medical Center

2014-2015Interim Director of Clinical Microbiology, University of Maryland Pathology Associates

2014-PresentCo-Director of Bio-containment Unit, Laboratory,University of Maryland Medical Center

2015-PresentDirector of Clinical Microbiology, University of Maryland Medical Center

2015-PresentDirector of Clinical Microbiology, University of Maryland Pathology Associates

Administrative Service

Institutional Service

2006-2014Associate Director of Clinical Microbiology and Virology Laboratories

Laboratories of Pathology, University of Maryland Medical Center

2006-PresentMember, UMMC Infection Control Executive Committee

2008-2010Associate Member, Graduate Faculty

2009-PresentMember, UMMC Pandemic Steering Committee

2010-Present Regular Member, Graduate Faculty

2011-PresentMember, Host Defenses and Infectious Diseases Committee, University of Maryland School of Medicine

2011-PresentInterviewer, Office of Admissions, University of Maryland School of Medicine

2011-PresentMember, UMMC Antimicrobial Subcommittee of the P&T Committee

2011-PresentMember, Pathology Residency Committee

2011Judge, Medical Student Research Day

2013-PresentMember, Clinical Competency Committee, Department of Pathology

2014-2015Interim Directorof Clinical Microbiology and Virology Laboratories

Laboratories of Pathology, University of Maryland Medical Center

2014-2015Interim Director of Clinical Microbiology, University of Maryland Pathology Associates

2014-PresentMember, UMMC Strategic Steering Committee-Ebola Preparation Plan

2014-PresentMember, UMMC Laboratory Services Committee-Ebola Preparation Plan

2014-PresentCo-Director of Bio-containment Unit, Laboratory,University of Maryland Medical Center

2015-PresentMember, Quality Assurance Oversight Committee, University of Maryland Medical Center, Laboratories of Pathology

2015-PresentMember, Institutional BioSafety Committee, University of Maryland, Baltimore

2016-PresentMember, UMMC Laboratory Utilization Committee

2015-PresentDirector of Clinical Microbiology, University of Maryland Medical Center

2015-PresentDirector of Clinical Microbiology, University of Maryland Pathology Associates

Local Service

2009 Member of ASM Division C Chair nomination Committee

2010-2014 Judge for J. Howard Brown Award given by the Maryland Branch ASM

2010-PresentMember, Maryland MDRO Collaborative

2011-2014Board of Directors, American Society of Microbiology, Maryland Branch

2012-2013President, American Society of Microbiology, Maryland Branch

National Service

2008-PresentReviewer, Diagnostic Microbiology and Infectious Diseases(1x/year)

2010-PresentReviewer, European Journal of Clinical Microbiology and Infectious Diseases(1x/year)

2011-PresentReviewer, Journal of Medical Microbiology(1x/year)

2011-PresentReviewer, Journal of Clinical Microbiology(3x/year)

2011-PresentReviewer, Journal of Microbiological Methods(0-1x/year)

2011-PresentReviewer, American Journal of Infection Control(0-1x/year)

2012-PresentReviewer, PLOS ONE(2x/year)

2012-PresentMember, Clinical Microbiology Mentoring Committee of the Professional Practice Committee, American Society of Microbiology (Term until 2017)

2012-2014Member, The American Boardof Medical Microbiology (ABMM) Validation Committee

2012American Society of Microbiology Career Session (June 16, 2012)

2012-PresentReviewer, Infections(0-1x/year)

2012-PresentReviewer, Journal of Antimicrobial Chemotherapy(1x/year)

2014-PresentAmerican Society of Microbiology Division C Finance Committee

2014Member, Expert Panel, UPMC Center for Health Security, Improving the Odds: What government can do to encourage the development of commercially viable infectious disease diagnostics.

2014-PresentMember, The American Boardof Medical Microbiology (ABMM) Item Committee

2014American Society of Microbiology Convener for Diagnostic Microbiology and Epidemiology Session for the 114th General Meeting May 18, 2014: The Evolving Role on Active Surveillance for MDROs for Infection Prevention: The Impact of New Landmark Studies upon the Clinical Microbiologist.

2014-PresentReviewer, Annals of Clinical Microbiology and Antimicrobials(0-1x/year)

2015-PresentMember, Editorial Board, Journal of Clinical Microbiology (2017)

2015-PresentMember, Methods Application and Interpretation Working Group for the Subcommittee on Antimicrobial Susceptibility Testing, Clinical Laboratory Standards Institute (CLSI)

2016-PresentMember, Editorial Board, Journal of Applied Laboratory Medicine(2019)

2016-PresentReviewer, Journal of Applied Laboratory Medicine(2x/year)

2016-PresentMember, Carbapenemase Inactivation Method Working Group, Clinical laboratory Standards Institute (CLSI)

2016American Society of Microbiology Convener for Clinical Science and Epidemiology Symposium for the ASM Microbe 2016 Meeting June 18, 2016: Guess the Bacterial Resistance Mechanism

2016American Society of Microbiology Convener for Clinical Science and Epidemiology Symposium for the ASM Microbe 2016 Meeting June 19, 2016: Optimal Use of Rapid Diagnostics in the Clinical Microbiology Laboratory for Quality Improvement and Clinical Care

2016Study Section Member, Defense Medical Research and Development Program

2016-presentScientific Lead, CDC/ASM Laboratory Medicine Best Practices committee on Bloodstream Infections

2016-presentMember, Association of Public Health Laboratories (APHL) Biosafety and Biosecurity Partners Forum (recently appointed by SHEA)

Teaching Service

Prior to Faculty Appointment

1998Laboratory Assistant, Pathogenic Microbiology,

3rd year Medical Technology Students- 6 contact hours/week

Department of Medical and Research Technology, University of MarylandSchool of Medicine

1998Lecturer

Pathogenic Microbiology

3rd year Medical Technology Students- 4 contact hours

Department of Medical and Research Technology, University of Maryland School of Medicine

1999-2001Laboratory Assistant

Dental Microbiology

2nd year Dental Students – 1 contact hour/week

University of MarylandDental School

Faculty Appointment

Basic Sciences

2004-PresentPreceptor, Laboratory Small Group

Host Defenses and Infectious Diseases Laboratory

Second year Medical Students

40 students/year, 6 hours/year

University of MarylandSchool of Medicine

2005-2007Lecturer

Seminars in Biological Terrorism

Smallpox

6-8 students, 2 hours/year

Department of Pathology, University of MarylandSchool of Medicine

2006-PresentMember of Thesis/Dissertation Committee

Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine

7 graduate students, 20 hours/year per mentee

2007Lecturer

Emerging Infections (NURS 418)

Molecular Epidemiology

20 nursing students, 2 hours/year

University of MarylandSchool of Nursing

2007-2013Research Mentor

Molecular Epidemiology Practicum

Epidemiology Ph.D. Graduate Students

Molecular Epidemiology Track, University of Maryland Graduate School

2 students/ 20 hours

2009-PresentLecturer

Clinical Virology (MEDT 471)

15 students, 6 hours/year

Department of Medical and Research Technology,University of MarylandSchool of Medicine

2009-PresentMember of Thesis/Dissertation Committee

Department of Medical and Research Technology, University of Maryland School of Medicine

1 graduate student, 20 hours/year per mentee

2010Lecturer

Pathogenic Microbiology (MEDT 472)

12 students, 4 hours/year

Department of Medical and Research Technology,University of MarylandSchool of Medicine

2010-PresentPrimary Mentor

Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine

3 graduate students, 104 hours/year per mentee

2011-PresentLecturer, Bacteriology Laboratory I, II, and III

Host Defenses and Infectious Diseases Laboratory

Second year Medical Students

160 students/year, 6 hours/year

University of MarylandSchool of Medicine

2015-PresentLecturer, Principles of Pharmacology

University of Maryland, Baltimore

School of Medicine

Department of Pharmacology

10 graduate students, 6 hours/year

Clinical Sciences(Fellows and Residents)

2003-PresentMedical Microbiology Plate Rounds

Clinical Microbiology Laboratory

1st and 2nd year Infectious Disease Fellows, 3rd or 4th year Medical Students, Pathology Residents and Attendings

12-15 fellows per year, 2-3 medical students, 1 pathology resident, 1-2 faculty members/year

78 contact hours/year

Department of Pathology, University of Maryland Medical Center

2006-PresentMentor

Medical Microbiology Rotations

5-6 pathology residents, 1-2 medical students

2 hours/ rotation

Microbiology Laboratory, University of Maryland Medical Center

2006-PresentMedical Microbiology Lectures

Pathology Residents

10-12 residents, 8 contact hours

Department of Pathology,University of Maryland Medical Center

2014-PresentMedical Microbiology Rotations

Infectious Disease Fellows

10-12 fellows/year, 10 contact hours

Department of Medicine, Division of Infectious Diseases, University of Maryland Medical Center

Students/Residents/Fellows Mentored

*Indicates that I serve(d) as the primary mentor

Grant Support

Active Grants

10/01/11 - 03/31/17Role: Co-Investigator (10%) PI: M.C. Roghmann

(NCE)“Metagenomic Studies of MRSA Colonization”

Veterans Health Administration CSR&D

Total Direct Costs: $508,781

Total Indirect Costs: $0

Direct laboratory work and personnel and review, interpret, analyze, and publish data.

07/01/12 - 12/31/17 Role: Co-Investigator (10%) PI: M.C. Roghmann

(NCE)“Modifying Isolation Precautions for MRSA in Non-acute Care

Settings”

VA Merit Grant Health Services R&D

RII10-154

Total Direct Costs: $1,035,459

Total Indirect Costs: $0

Direct laboratory work and personnel and review, interpret, analyze, and publish data.

04/01/14 - 03/31/16Role: Co-Investigator (5%)PI: K. Kotloff

(NCE)“Incidence, Mode of Transmission, and Sequelae of Community-Acquired Methicillin Resistant Staphylococcus aureus Infection in the Neonatal Intensive Care Unit and the Effectiveness of Decolonization”

NIH VTEU

Direct Costs: $822,310

Direct laboratory work and personnel and review, interpret, analyze, and publish data.

08/01/15 - 07/31/19Role: Co-Investigator (5%) PI: Thom

Removing barriers to hand hygiene and glove compliance: Evaluation of two novel time-efficient interventions

Agency for Healthcare Research and Quality

R01 HS024108-01

Direct and Indirect cost:$1,571,807

Direct laboratory work and personnel and review, interpret, analyze, and publish data.

09/30/15 - 12/29/16Role: Principal Investigator (2%)

Sentinel Site Surveillance for AR Organisms II

CDC-SHEPheRD Program Contract RFTOP 2015-008

Direct Cost: $78,500

Indirect Cost: $20,500

9/15/15-9/14/17Role: Co-investigator (10%)PI: Cross

Development of a multivalent vaccine to prevent invasive infections and colonization with Klebsiella pneumoniae and Pseudomonas aeruginosa.

Nosocimial Vaccine Company

Total Direct Costs: $3, 239,933

Provide bacterial strains and expertise in Klebsiella pneumoniae and Pseudomonas aeruginosa.

09/30/15 - 09/29/18 Role: Co-investigator(10%) PI: Harris

Epicenters for the Prevention of Healthcare Associated Infections (HAI) - Cycle II

Centers for Disease Control

1U54CK0000450-01

Direct and Indirect cost:$1,432,368

Direct laboratory work and personnel and review, interpret, analyze, and publish data.

10/01/15-3/31/18Role: Co-investigator (10%) PI: Harris

“Does Universal Glove and Gown use decrease carbapenem-resistance Gram-negative bacteria”

AHRQ R18 HS024045

Total Directs: $770,800

Total Indirects: $417,310

Direct laboratory work and personnel and review, interpret, analyze, and publish data.

03/01/16-02/28/18Role: Co-Investigator (10%) PI: M.C. Roghmann

“Transmission of Antibiotic-resistant Gram-negative Bacteria in Nursing Homes.”

National Institute of Allergy and Infectious Diseases

R03-A1-122223

Total Direct Costs: $153,000

Direct laboratory work and personnel and review, interpret, analyze, and publish data.

09/01/2016-08/31-17Role:Principal Investigator (2%)

“Understanding the workflow of positive blood cultures from sampling to results.”

Q-Linea

Direct Costs: $9,999

8/10/16-07/31/2020Role: Co-Investigator (10%) PI: Harris

“Epidemiology of CRE and MRSA transmission: patient and organism factors”

NIH National Institute of Allergy and Infectious Diseases

1R01AL121146-01

Total Directs: $1,800,599

Direct laboratory work and personnel and review, interpret, analyze, and publish data.

09/15/16-11/14/17Role: Co-Principal Investigator (10%)

“Identification of Microbial disruption indices (MDI) predictive of colonization and dominance by multi-drug resistant Pseudomonas aeruginosa. “

Centers for Disease Control and Prevention

BAA 2016-N-17812

Total Costs: $459,721

Total Indirects: $606,837

Pending Grants

10/01/16-09/30/17Role:Principal Investigator (2%)

“A Clinical Evaluation of a Gastrointestinal Infection panel Assay system (ACEGIS)”

Applied BioCode

Total Cost: $100,000

04/1/17-03/31/22Role: Sub-award PI (10%)PI: Bachman

“Integrated modeling of Klebsiella pneumoniae infections based on bacterial genotype, patient factors and colonization status”

NIH R01 AI 125307 01 A1

NIH-DHHS-US

Total Cost: $312,770 sub award

TotalCost: $2,713,340

Completed Grants

09/01/05 - 07/31/12Role: Investigator/Scholar (75%)PI: A.R. Shuldiner

“Transmission of Plasmid Mediated AmpC β-lactamases”

University of Maryland Multidisciplinary Research Career Development Program (MCRDP)

NIH K12RR023250

Total Direct Costs: $12,309,704

06/01/07 - 11/01/07Role: PI (5%)

“Culture results for patients with positive blood cultures”

AdvanDx

Total Direct Costs: $3,000

08/01/07 - 07/31/08Role: PI (75%)

“Understanding Resistance Mechanisms in Fecal Microorganisms”

University of Maryland GCRC

Total Direct Costs: $10,000

09/30/07 - 09/29/08Role: Co-Investigator (in kind/mentor)PI: K Kreisel

“Risk Factors and Outcomes of Infections Due to USA300 Methicillin Resistant Staphylococcus aureus”

CDC R36 Grant for Public Health Research Dissertation

Program Announcement PAR-07-231

Total Direct Costs: $35,000

10/22/07 - 12/31/07Role: PI (15%)

“BacLite for the detection of MRSA”

3M Medical Diagnostics

Total Direct Costs: $40,000

07/01/08 - 06/30/09Role: Co-PI (5%)PI: R. Venezia

“Detection of MRSA from Blood Cultures”

Microphage

Total Direct Costs: $21,000

02/01/10 - 02/01/11Role: PI (5%)

“Clinical Validation of the Molecular-based BD GeneOhm VanR assay for the presumptive identification of vancomycin resistant Enterococci in perianal and/or rectal specimens”

Becton Dickinson

Total Direct Costs: $75,000

04/15/10 - 07/31/11Role: Site PI(in kind/mentor)PI: M. Schweizer

“Linezolid Therapy and Outcomes in Patients with Post-Influenza Staphylococcus aureus Pneumonia, Controlling for Patient, Pathogen, and Treatment Characteristics”

Pfizer

06/01/10 - 11/30/13Role: Co-Investigator (5%)PI: A.D. Harris

“Epidemiology of emerging pathogens among hospitalized patients”

2R01AI060859-05 Renewal

Direct Costs: $900,000

Indirect Costs: $436,500

Total Direct Costs: $100,000

06/28/10 - 12/01/11 Role: Co-Investigator (5%)PI: K Thom

Maryland MDR Acinetobacter Prevalence Survey

3U50CI000485 Maryland Department of Health and Mental Hygiene

Direct Costs: $178,000

07/26/10 - 07/25/12Role: Co-Investigator (5%) PI: J. Furuno

“Using Nursing Home Antibiograms to Improve Antibiotic Prescribing and Delivery”

AHRQ HHSA290200600020I

Direct Costs:$621,298

08/16/10 - 08/14/13Role: Co-Investigator (5%)PI: A.D. Harris

“Novel Interventions to Decrease Healthcare Associated Infections”

AHRQ (Choice)

Direct Costs: $1,064,827

03/01/11 - 02/28/15Role: Co-Investigator (5%)PI: M.C. Roghmann

“Human Microbiome and Healthcare-associated Infections”

National Institutes of Health, National Institute of Allergy and Infectious Diseases

R01

Total Direct Costs: $1,134,557

Total Indirect Costs: $567,279

08/01/11 - 07/31/14Role: Co-Investigator (10%)PI: M.C. Roghmann

“Modifying Isolation Precautions for MRSA in Long Care Setting”

Agency for Healthcare Research and Quality

Total Direct Costs: $1,012,297

Total Indirect Costs: $338,262

10/01/11 - 09/30/12Role: PI (no salary for PI)

“Drug Resistant Gram Negative Microorganisms in VA Long Term Care Facilities”

Baltimore Research and Education Foundation, Inc.

Total Direct Cost: $19,500

01/31/12 - 02/01/14Role: PI (10%)

“A novel agent to decrease contamination of hospital scrubs”

BioMed Protect Inc.

Total Direct Costs: $80, 845

Total Indirect Costs: $43, 252

The contract is with the UMB SOM Center for Clinical Trials.

08/01/12 - 07/31/13Role: Principal Investigator (2%)